Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 5, 1998, Pages 444-450

  Dördelmann, Michael ^a   Reiter, Alfred ^a   Zimmermann, Martin ^a   Fengler, Rüdiger ^b   Henze, Günter ^b   Riehm, Hansjörg ^a   Schrappe, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Acute lymphoblastic leukemia; Childhood; Methotrexate; Testicular relapse

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL OBSERVATION; DRUG EFFICACY; DRUG SCREENING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TESTIS CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; METHOTREXATE; RECURRENCE; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS;

EID: 17444445231     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199809000-00007     Document Type: Article

References (30)

1. Fengler R, Henze G, Langermann HJ, et al. Frequency and therapy results of testicular relapse in childhood lymphoblastic leukemia. Klin Pädiatr 1982;194:204-8.
2. Nachman J, Palmer NF, Sather HN, et al. Open-wedge testicular biopsy in childhood acute lymphoblastic leukemia after two years of maintenance therapy: diagnostic accuracy and influence on outcome-a report from Children's Cancer Study Group. Blood 1990;75:1051-5.
3. Rivera GK, Raimondi SC, Hancock ML, et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational chemotherapy. Lancet 1991;337:61-6.
4. Schorin MA, Blattner S, Gelber RD, et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol 1994;12:740-7.
5. Camitta B, Mahoney D, Leventhal B, et al. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia. J Clin Oncol 1994;12:1383-9.
6. Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994;84:3122-33.
7. Chessells JM, Bailey CC, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukemia. Lancet 1995;345:143-8.
8. Moe PJ, Seip M, Finne PH. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway: preliminary results of a national treatment program. Acta Paediatr Scand 1981;70:73-9.
9. Freeman AI, Weinberg V, Brecher ML, et al. Comparison of inter mediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. N Engl J Med 1983;308:477-84.
10. Brecher ML, Weinberg V, Boyett JM, et al. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse. Cancer 1986;58:1024-8.
11. Bowman WP, Aur RJA, Hustu HO, et al. Isolated testicular relapse in acute lymphoblastic leukemia of childhood: categories and influence on survival. J Clin Oncol 1984;2:924-9.
12. Russo A, Schiliro G. The enigma of testicular leukemia: a critical review. Med Pediatr Oncol 1986;14:300-5.
13. Schrappe M, Beck J, Brandeis WE, et al. Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81. Klin Pädiatr 1987;199:133-50.
14. Riehm H, Gadner H, Henze G, et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Hamatol Bluttransfus 1990;33:439-50.
15. Ludwig WD, Bartram CR, Ritter J, et al. Ambigous phenotypes and genotypes in 16 children as characterized by multiparameter analysis. Blood 1988;71:1518.
16. Harbott J, Ritterbach J, Ludwig WD, et al. Clinical significance of cytogenetic studies in childhood acute leukemia: experience of the BFM trials. Recent Results Cancer Res 1993;131:123.
17. Hiddemann W, Wörmann B, Ritter J, et al. Frequency and clinical significance of DNA aneuploidy in acute leukemia. Ann N Y Acad Sci 1986;468:227.
18. Riehm H, Reiter A, Schrappe M, et al. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 1987;199:151-60.
19. Henze G, Fengler R, Reiter A, et al. Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia. Hamatol Bluttransfus 1990;33:483-8.
20. Bührer C, Henze G. Hofmann J, et al. Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials. Hamatol Bluttransfus 1990;33:500-3.
21. Pui CH. Childhood leukemias. N Engl J Med 1995;332:1618-30.
22. Pinkel D. Selecting treatment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:4-6.
23. Langermann HJ, Henze G, Wulf M, et al. Abschätzung der Tumorzellmasse bei der akuten lymphoblastischen Leukämie im Kindesalter: Prognostische Bedeutung und praktische Anwendung. Klin Pädiatr 1982;194:209.
24. Eden OB, Lilleyman JS, Richards S. Testicular irradiation in childhood lymphoblastic leukaemia. Br J Haematol 1990;75:496-8.
25. Evans WE. Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity. Blut 1988;56:241-8.
26. Riccardi R, Vigersky RA, Barnes S, et al. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Res 1982;42:1617-19.
27. Evans WE, Crom WR, Abromowitch M, et al. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. N Engl J Med 1986;314:471-7.
28. Niemeyer CM, Gelber RD, Tarbell NJ, et al. Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update). Blood 1991;78:2514-9.
29. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York, NY: Jon Wiley and Sons, 1980;163-8.
30. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals and other measures of statistical accuracy. Statistical Science 1986;1:54-77.